Best Agrolife Ltd

Best Agrolife Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Best Agrolife Ltd

₹ 390 2.12%
02 Jan - close price
bestagrolife.com BSE: 539660 NSE: BESTAGRO
About

Best Agrolife (formerly known as Sahyog Multibase Limited) [1] is a leading agrochemicals manufacturer in India and is among the top 15 agrochemicals companies in the country. It is one of the fastest growing manufacturers of Technicals, Formulations, Intermediates and Public Health products. Best Agrochem Private Limited was amalgamated with the Co. in April 2018.

It offers more than 70 Formulations in the form of Insecticides, Herbicides, Fungicides and Plant Growth Regulators, which are developed from active ingredients manufactured in-house. As part of its P2P set-up, Best Agrolife caters to several blue-chip corporates and leading MNCs from India and abroad. [2]

Key Points

Business Overview
The company is the 13th Largest Indian Agrochemical Company, with a portfolio of 490+ formulations and 115+ technical manufacturing licenses. It offers a wide range of herbicides, insecticides, fungicides, and plant growth regulators including Ronfen, Citigen, Tricolor, Azaro, Cubax Power, etc. [1] [2] [3]

Website BSE NSE
  • Market Cap ₹ 923 Cr.
  • Current Price ₹ 390
  • High / Low ₹ 620 / 244
  • Stock P/E 72.1
  • Book Value ₹ 342
  • Dividend Yield 0.51 %
  • ROCE 12.9 %
  • ROE 9.95 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Stock is trading at 1.14 times its book value

Cons

  • Company has low interest coverage ratio.
  • Debtor days have increased from 92.3 to 113 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Fertilizers & Agrochemicals Pesticides & Agrochemicals

Part of BSE SmallCap BSE Allcap BSE Commodities

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
700 328 254 612 811 314 135 519 747 274 274 381 517
518 270 247 482 667 296 202 465 600 280 270 335 439
Operating Profit 183 58 7 130 144 19 -67 55 147 -6 4 46 78
OPM % 26% 18% 3% 21% 18% 6% -50% 11% 20% -2% 2% 12% 15%
1 1 1 4 -3 1 1 3 1 -0 1 4 -2
Interest 9 10 13 12 15 19 15 16 16 16 17 14 13
Depreciation 6 6 7 7 8 6 11 10 10 11 12 10 10
Profit before tax 168 43 -12 115 118 -6 -92 32 121 -33 -24 26 52
Tax % 23% 29% -28% 21% 19% 3% -22% 33% 22% -26% -9% 22% 26%
130 31 -8 90 95 -7 -72 21 95 -24 -22 20 39
EPS in Rs 54.90 12.95 -3.56 38.27 40.12 -2.80 -30.66 9.00 40.03 -10.22 -9.26 8.42 16.46
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
127 151 905 1,211 1,746 1,873 1,814 1,447
126 154 854 1,045 1,432 1,648 1,614 1,325
Operating Profit 1 -2 51 166 314 226 200 122
OPM % 0% -1% 6% 14% 18% 12% 11% 8%
1 4 7 2 3 3 5 3
Interest 1 2 5 15 39 62 66 60
Depreciation 0 0 3 12 24 33 43 43
Profit before tax 0 0 51 141 253 134 96 21
Tax % 575% 100% 27% 26% 24% 21% 27%
-0 0 37 105 192 106 70 13
EPS in Rs -0.65 0.03 16.83 44.31 81.27 44.94 29.56 5.40
Dividend Payout % -0% 798% 12% 5% 4% 7% 10%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 14%
TTM: -16%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: -13%
TTM: -65%
Stock Price CAGR
10 Years: %
5 Years: -6%
3 Years: -35%
1 Year: -37%
Return on Equity
10 Years: %
5 Years: %
3 Years: 21%
Last Year: 10%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 8 8 22 24 24 24 24 24
Reserves 46 48 108 306 504 623 734 786
0 19 33 270 568 637 478 436
63 35 209 384 380 729 713 718
Total Liabilities 117 110 372 984 1,475 2,013 1,949 1,963
0 0 19 180 203 362 374 356
CWIP -0 -0 4 5 14 15 1 1
Investments 32 3 -0 -0 -0 -0 1 1
85 107 349 800 1,258 1,636 1,573 1,605
Total Assets 117 110 372 984 1,475 2,013 1,949 1,963

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
-14 -41 13 -60 -180 36 228
-34 31 8 -15 -19 -63 -29
48 10 -11 67 248 -1 -199
Net Cash Flow 0 -0 10 -8 49 -29 -0

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 85 87 53 77 73 91 113
Inventory Days 67 199 391 864 577
Days Payable 72 124 167 521 404
Cash Conversion Cycle 85 87 48 152 297 434 286
Working Capital Days 60 150 33 52 47 43 64
ROCE % 0% 41% 34% 16% 13%

Shareholding Pattern

Numbers in percentages

43 Recently
Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
48.20% 50.10% 50.10% 50.10% 50.10% 50.10% 50.10% 50.10% 50.10% 50.44% 50.44% 50.44%
12.05% 11.48% 10.84% 9.86% 8.86% 8.77% 8.73% 8.03% 5.11% 5.80% 5.75% 5.75%
2.57% 2.58% 2.55% 2.63% 2.53% 2.53% 2.53% 2.67% 2.74% 2.74% 2.74% 2.11%
37.16% 35.84% 36.50% 37.42% 38.50% 38.60% 38.62% 39.18% 42.06% 41.01% 41.05% 41.70%
No. of Shareholders 21,20623,03927,20031,94037,57139,86141,57040,57337,66637,49436,63037,181

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls